Korean Circ J.  2021 Jul;51(7):639-641. 10.4070/kcj.2021.0194.

Is Left Atrial Appendage Occlusion Always Better than Direct Oral Anticoagulants?

• Kim J

• KMID: 2517493
• DOI: http://doi.org/10.4070/kcj.2021.0194

Reference

1. Lee SR, Choi EK, Han KD, Cha MJ, Oh S. Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA₂DS₂-VASc score in the entire Korean population. Int J Cardiol. 2017; 236:226–231. PMID: 28233629.

2. Yu HT, Yang PS, Hwang J, et al. Social inequalities of oral anticoagulation after the introduction of non-vitamin K antagonists in patients with atrial fibrillation. Korean Circ J. 2020; 50:267–277. PMID: 32100483.

3. Banerjee A, Benedetto V, Gichuru P, et al. Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study. Heart. 2020; 106:119–126. PMID: 31601729.

4. Reddy VY, Sievert H, Halperin J, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014; 312:1988–1998. PMID: 25399274.

5. Nielsen-Kudsk JE, Korsholm K, Damgaard D, et al. Clinical outcomes associated with left atrial appendage occlusion versus direct oral anticoagulation in atrial fibrillation. JACC Cardiovasc Interv. 2021; 14:69–78. PMID: 33413867.

6. Lee O, Kim YD, Kim JS, et al. Percutaneous left atrial appendage occlusion yields favorable neurological outcomes in patients with non-valvular atrial fibrillation. Korean Circ J. 2021; 51:626–638. PMID: 34227275.

7. Paciaroni M, Agnelli G, Caso V, et al. Causes and risk factors of cerebral ischemic events in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants for stroke prevention. Stroke. 2019; 50:2168–2174. PMID: 31234756.

8. Langhorne P, O'Donnell MJ, Chin SL, et al. Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study. Lancet. 2018; 391:2019–2027. PMID: 29864018.

9. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2002; CD000197. PMID: 11869570.

10. Held C, Hylek EM, Alexander JH, et al. Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial. Eur Heart J. 2015; 36:1264–1272. PMID: 25499871.